Eric Halioua

Eric Halioua

Company: PDC*line Pharma

Job title: President and Chief Executive Officer


Reporting Clinical Data from a First-in-Class Plasmacytoid Dendritic Cell Line Vaccine in Patients with Metastatic NSCLC 10:00 am

• Understanding the characteristics and applications of the PDC*vac technology as a novel allogeneic cancer vaccine • Reviewing early safety, tolerability, and immunogenicity findings from this phase one trial • Discussing initial signs of clinical activity associated with the vaccine in NSCLC patientsRead more

day: Day Two

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.